Evidence map›Paper›PMID 15784585›Full record

ArticleInfection and immunity2005

Haemophilus ducreyi Outer membrane determinants, including DsrA, define two clonal populations.

Catherine Dinitra White, Isabelle Leduc, Bonnie Olsen, Chrystina Jeter, Chavala Harris, Christopher Elkins

Open access · greenAbstract read
In one paragraph

Article in Infection and immunity, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 64 citations in OpenAlex.

  1. A Class IInfection and immunity · 2019
    Trial
  2. Molecular pathogenesis ofMicrobiology and molecular biology reviews : MMBR · 2025
    Review
  3. Infections caused byClinical microbiology reviews · 2024
    Review
  4. Review
  5. Interactions of the Skin PathogenFrontiers in immunology · 2020
    Review
  6. Multiple Class I and Class II Haemophilus ducreyi Strains Cause Cutaneous Ulcers in Children on an Endemic Island.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2018
    Article
  7. Article
  8. Article
  9. Article
  10. Defining Potential Vaccine Targets of Haemophilus ducreyi Trimeric Autotransporter Adhesin DsrA.Monoclonal antibodies in immunodiagnosis and immunotherapy · 2015
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Catherine Dinitra WhiteDepartment of Medicine, School of Medicine, University of North Carolina, Chapel Hill, NC 27599, USA.
Isabelle Leduc
Bonnie Olsen
Chrystina Jeter
Chavala Harris
Christopher Elkins
University of North Carolina at Chapel Hill · US

Funding

SEEDING POSTDOCTORAL INNOVATORS IN RESEARCH &EDUCATIONK12GM000678 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DONALD T LYSLE, Kathryn Joanna Reissner · 1999 to 2026
$30.9M
Trichomonas Typing SystemU19AI031496 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI HOBBS, MARCIA METZGAR · 1995 to 2014
$24.9M
Vaccine Studies of the hemoglobin receptor of H. ducreyiR01AI053593 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI LEDUC, ISABELLE · 2003 to 2009
$1.5M
THE EPIDEMIOLOGY OF STDS IN RURAL NORTH CAROLINAU01AI031496 · NIAID · UNIVERSITY OF NORTH CAROLINA CHAPEL HILL · PI SPARLING, PHILIP FREDERICK · 1991 to 1994
–
NIAID NIH HHS AI 31496NIAID NIH HHS R01 AI053593NIAID NIH HHS R01-AI 53593-02NIAID NIH HHS U19 AI031496NIGMS NIH HHS GM000678NIGMS NIH HHS K12 GM000678
6 · The paper itself

Abstract

The Haemophilus ducreyi outer membrane component DsrA (for ducreyi serum resistance A) is necessary for complete resistance to normal human serum (NHS). When DsrA expression in 19 temporally and geographically diverse clinical isolates of H. ducreyi was examined by Western blotting, 5 of the strains expressed a different immunotype of the DsrA protein (DsrA(II)) than the well-characterized prototypical strain 35000HP (DsrA(I)). The predicted DsrA proteins expressed by the DsrA(II) strains were 100% identical to each other but only 48% identical to that of strain 35000HP. In addition to the DsrA(II) protein, class II strains also expressed variant forms of other outer membrane proteins (OMPs) including NcaA (necessary for collagen adhesion A), DltA (ducreyi lectin A), Hlp (H. ducreyi lipoprotein), major OMP, and/or OmpA2 (for OMP A2) and synthesized a distinct, faster-migrating lipooligosaccharide. Based on these data, strains expressing DsrA(I) were termed class I, and those expressing DsrA(II) were termed class II. Expression of dsrA(II) from strain CIP 542 ATCC in the class I dsrA(I) mutant FX517 (35000HP background), which does not express a DsrA protein, rendered this strain resistant to 50% NHS. This demonstrates that DsrA(II) protein is also critical to serum resistance. Taken together, these results indicate that there are two clonal populations of H. ducreyi. The implications of two classes of H. ducreyi strains differing in important antigenic outer membrane components are discussed.

Indexed as

Amino Acid SequenceBacterial Outer Membrane ProteinsBlood Bactericidal ActivityHaemophilus ducreyiHumansLipopolysaccharidesMolecular Sequence DataBacterial Outer Membrane Proteinslipid-linked oligosaccharidesLipopolysaccharides

Identifiers

PMID15784585
PMCPMC1087395
OpenAlexW2161945304

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.